AngioDynamics CEO Vascular access and surgery device manufacturer AngioDynamics Inc. appointed James C. Clemmer president and CEO effective April 4. Clemmer succeeds Joseph M. DeVivo , who serv
The US market for neurointerventional systems is expected to exhibit healthy growth over the next five years, with a compound annual rate of 6.5%, from approximately $617.1 million in 2013 to an estim
Neurointerventional solutions for treating and preventing stroke continue to gain momentum, and several device-based treatments received a boost from new research presented at this year’s Internation
Neurointerventional solutions for treating and preventing stroke continue to gain momentum, and several device-based treatments received a boost from new research presented at this year’s Internation